Divi S Laboratories Ltd

NSE: DIVISLAB · Pharmaceuticals · sector

₹9,050.00NSE close 2026-10-26

Key numbers

Market cap₹2,39,825 cr

Price₹9,050.00

52w high / low₹9,740 / ₹5,648

P/E82.1xSector median 27.9x

P/B14.3xSector median 2.9x

Book value₹632.5

Dividend yield0.34%Sector median 0.48%

ROE18.4%Sector median 11.7%

ROCE23.0%Sector median 12.3%

OPM34.7%Sector median 14.0%

Debt / equity0.00xSector median 0.16x

EV/EBITDA60.7xSector median 18.6x

Interest cover148.5x

Current ratio5.43x

Sales growth 3y+10.8%Sector median +9.6%

Profit growth 3y+12.1%Sector median +13.3%

PEG6.79x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹3,414 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 148.5x in the last 12 months.
No promoter shares are pledged.
Operating cash flow was below net profit in 3 of the last 5 years (FY25, FY24, FY22).
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 15% of net profit in the last 12 months.
Dividend paid in 5 of the last 5 financial years.
Price ₹9,050.00 on 2026-10-26: -7.1% from the 52-week high, +60.2% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹9,602.00 · low ₹5,372.85

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2,338	2,319	2,585	2,410	2,715	2,604	2,831	3,080
EBITDA	716	743	886	729	888	816	934	1,255
OPM %	30.6%	32.0%	34.3%	30.2%	32.7%	31.3%	33.0%	40.7%
Other income	106	82	86	119	145	88	155	64
Net profit	510	589	662	545	689	583	751	902
EPS (₹)	19.20	22.20	24.93	20.49	25.97	21.98	28.31	33.95
Revenue YoY					+16.1%	+12.3%	+9.5%	+27.8%
Profit YoY					+35.1%	-1.0%	+13.4%	+65.5%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	8,960	7,768	7,845	9,360	10,560	11,230
EBITDA	3,882	2,368	2,205	2,968	3,367	3,893
Net profit	2,960	1,823	1,600	2,191	2,568	2,925
EPS (₹)	111.52	68.69	60.27	82.53	96.75	110.21
Revenue growth		-13.3%	+1.0%	+19.3%	+12.8%	+16.4%
Profit growth		-38.4%	-12.3%	+36.9%	+17.2%	+26.8%
Dividend / share (₹)	20.00	30.00	30.00	30.00	30.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+10.8%	+8.7%	+16.3%
Net profit	+12.1%	+5.3%	+26.8%
EPS	+12.1%	+5.3%	–
Share price	–	+24.5% (2y)	+39.5%

Balance sheet

₹ cr	FY22	FY23	FY24	FY25	FY26
Shareholders' equity	–	12,767	13,571	14,969	16,761
Borrowings	–	0	0	2	0
Cash & equivalents	–	4,213	3,980	3,715	3,414
Total assets	–	14,439	15,470	16,932	20,033
Fixed assets	–	4,714	4,733	5,437	6,515
Capital work in progress	–	212	778	1,022	2,113
Investments	–	77	82	65	69
Receivables	–	1,793	2,156	2,731	2,984
Inventory	–	3,000	3,184	3,236	3,954
Payables	–	763	824	910	1,211

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	1,912	2,460	1,261	1,653	2,738
Cash from investing	-2,195	-2,708	-269	-804	-2,219
Cash from financing	-532	-797	-799	-799	-804
Capex	713	473	1,003	1,438	2,520
Free cash flow	1,199	1,987	258	215	218

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY22	FY23	FY24	FY25	FY26
ROE %	–	14.3%	11.8%	14.6%	15.3%
ROCE %	–	18.6%	16.0%	19.5%	20.4%
Debtor days	–	84	100	106	103
Inventory days	–	359	371	317	353
Payable days	–	91	96	89	108
Cash conversion cycle (days)	–	352	375	334	348
Working capital days	–	386	391	336	313

Shareholding

Holder	% (2026-09-30)
Promoters	51.88%
FIIs	20.38%
DIIs	19.17%
of which Mutual funds	14.66%
of which Insurance	3.48%
Government	0.00%
Public (non-institutions)	8.58%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	51.89%	51.89%	51.89%	51.89%	51.88%	51.88%	51.88%	51.88%

Promoter group	%
Satchandra Kiran Divi	20.34%
Nilima Prasad Divi	20.34%
Swarna Latha Divi	5.27%
Divi's Biotech Private Limited	3.01%
Murali Krishna Prasad Divi	2.85%
Madhusudana RAO Divi	0.06%
Radhakrishna RAO Divi	0.00%

Public holders above 1%	%
SBI Mutual Fund	3.58%
Government of Singapore	2.84%
HDFC Mutual Fund	2.18%
Life Insurance Corporation of India	1.59%
Axis Mutual Fund Trustee Limited	1.36%
Nippon Life India Trustee Ltd	1.27%
Government Pension Fund Global	1.12%

2,32,256 shareholders. Pledged: 0.00% of promoter shares.

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
LUPIN	₹89,616 cr	16.2x	4.0x	27.9%	27.9%	30.0%	+18.9%	0.61%

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2026-07-24	Dividend	Dividend - Rs 30 Per Share
2025-07-25	Dividend	Dividend - Rs 30 Per Share
2024-08-02	Dividend	Dividend - Rs 30 Per Share
2023-08-11	Dividend	Dividend - Rs 30 Per Share
2022-08-11	Dividend	Dividend - Rs 30 Per Share
2021-08-17	Dividend	Dividend - Rs 20 Per Share
2020-09-04	Other	Annual General Meeting
2020-02-25	Dividend	Interim Dividend - Rs 16 Per Share
2019-08-14	Dividend	Annual General Meeting/Dividend - Rs 16 Per Share
2018-08-31	Dividend	Annual General Meeting/Dividend- Rs 10 Per Share
2017-09-15	Dividend	Annual General Meeting/Dividend - Rs 10/- Per Share
2016-08-18	Other	Annnual General Meeting
2016-03-17	Dividend	Interim Dividend - Rs 10/- Per Share (Purpose Revised)
2015-09-23	Bonus	Bonus 1:1
2015-08-06	Dividend	Annual General Meeting/Dividend - Rs 20/- Per Share
2014-07-31	Dividend	Annual General Meeting / Dividend - Rs 20/- Per Share
2013-07-25	Dividend	Annual General Meeting/Dividend Rs 15/- Per Share
2012-07-26	Dividend	Annual General Meeting/ Dividend Of Rs. 13 Per Share
2011-06-16	Dividend	Annual General Meeting And Dividend Rs.10/- Per Share
2010-07-02	Dividend	Annual General Meeting And Dividend Rs.6/- Per Share

Documents

Links go to the original files on the exchange website.

About the company

Manufacture of Active Pharma Ingredients, Intermediates and Nutraceuticals: Manufacture of Active Pharma Ingredients, Intermediates and Nutraceuticals


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	DIVISLAB
BSE code	532488
ISIN	INE361B01024
Face value	₹2.0
Incorporated	1990-10-12
Website	www.divislabs.com
Plants (India / abroad)	4 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.